INTRODUCTION: Cytokines play a critical role in regulating the immune system. In the tumor microenvironment, they influence survival, proliferation, differentiation, and movement of both tumor and stromal cells, and regulate tumor interactions with the extracellular matrix. Given these biologic properties, there is reason to hypothesize that cytokine activity influences the pathogenesis of non-Hodgkin lymphoma (NHL). METHODS: We investigated the effect of genetic variation in cytokine genes on NHL prognosis and survival by evaluating genetic variation in individual SNPs as well as the combined effect of multiple deleterious genotypes. Survival information from 496 female incident NHL cases diagnosed during 1996-2000 in Connecticut were abstracted from Connecticut Tumor Registry in 2008. Survival analyses were conducted by comparing Kaplan-Meier curves and hazard ratios (HR) were computed using Cox proportional hazard models adjusting for demographic and tumor characteristics for genes that were suggested by previous studies to be associated with NHL survival. RESULTS: We found that the variant IL6 genotype is significantly associated (HR = 0.42; 95%CI: 0.23-0.77) with a decreased risk of death, as well as relapse and secondary cancer occurrence, among those with NHL. We also found that risk of death, relapse, and secondary cancers varied by specific SNPs for the follicular, DLBCL, and CLL/SLL histologic types. We identified combinations of polymorphisms whose combined deleterious effect significantly alter overall NHL survival and disease-free survival. CONCLUSION: Our study provides evidence that the identification of genetic polymorphisms in cytokine genes may help improve the prediction of NHL survival and prognosis.
INTRODUCTION: Cytokines play a critical role in regulating the immune system. In the tumor microenvironment, they influence survival, proliferation, differentiation, and movement of both tumor and stromal cells, and regulate tumor interactions with the extracellular matrix. Given these biologic properties, there is reason to hypothesize that cytokine activity influences the pathogenesis of non-Hodgkin lymphoma (NHL). METHODS: We investigated the effect of genetic variation in cytokine genes on NHL prognosis and survival by evaluating genetic variation in individual SNPs as well as the combined effect of multiple deleterious genotypes. Survival information from 496 female incident NHL cases diagnosed during 1996-2000 in Connecticut were abstracted from Connecticut Tumor Registry in 2008. Survival analyses were conducted by comparing Kaplan-Meier curves and hazard ratios (HR) were computed using Cox proportional hazard models adjusting for demographic and tumor characteristics for genes that were suggested by previous studies to be associated with NHL survival. RESULTS: We found that the variant IL6 genotype is significantly associated (HR = 0.42; 95%CI: 0.23-0.77) with a decreased risk of death, as well as relapse and secondary cancer occurrence, among those with NHL. We also found that risk of death, relapse, and secondary cancers varied by specific SNPs for the follicular, DLBCL, and CLL/SLL histologic types. We identified combinations of polymorphisms whose combined deleterious effect significantly alter overall NHL survival and disease-free survival. CONCLUSION: Our study provides evidence that the identification of genetic polymorphisms in cytokine genes may help improve the prediction of NHL survival and prognosis.
Authors: N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman; T A Lister; C D Bloomfield Journal: J Clin Oncol Date: 1999-12 Impact factor: 44.544
Authors: L Smallwood; R Allcock; F van Bockxmeer; N Warrington; L J Palmer; B Iacopetta; P E Norman Journal: Eur J Vasc Endovasc Surg Date: 2007-11-08 Impact factor: 7.069
Authors: L M Morton; T R Holford; B Leaderer; P Boyle; S H Zahm; Y Zhang; S Flynn; G Tallini; B Zhang; P H Owens; T Zheng Journal: Br J Cancer Date: 2003-12-01 Impact factor: 7.640
Authors: Hervé Ghesquieres; Susan L Slager; Fabrice Jardin; Amelie S Veron; Yan W Asmann; Matthew J Maurer; Thierry Fest; Thomas M Habermann; Marie C Bene; Anne J Novak; Sylvain Mareschal; Corinne Haioun; Thierry Lamy; Stephen M Ansell; Herve Tilly; Thomas E Witzig; George J Weiner; Andrew L Feldman; Ahmet Dogan; Julie M Cunningham; Curtis L Olswold; Thierry Jo Molina; Brian K Link; Noel Milpied; David G Cox; Gilles A Salles; James R Cerhan Journal: J Clin Oncol Date: 2015-10-12 Impact factor: 44.544
Authors: Fredrik Baecklund; Jia-Nee Foo; Paige Bracci; Hatef Darabi; Robert Karlsson; Henrik Hjalgrim; Richard Rosenquist; Hans-Olov Adami; Bengt Glimelius; Mads Melbye; Lucia Conde; Jianjun Liu; Keith Humphreys; Christine F Skibola; Karin E Smedby Journal: BMC Med Genet Date: 2014-10-08 Impact factor: 2.103
Authors: Kaspar René Nielsen; Rudi Steffensen; Mette Dahl Bendtsen; Maria Rodrigo-Domingo; John Baech; Thure Mors Haunstrup; Kim Steve Bergkvist; Alexander Schmitz; Julie Stoeveve Boedker; Preben Johansen; Karen Dybkaeær; Martin Boeøgsted; Hans Erik Johnsen Journal: PLoS One Date: 2015-10-08 Impact factor: 3.240